Crispr Therapeutics shares owned by Exchange Traded Concepts
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Exchange Traded Concepts
from 13F filings
Historical chart of Exchange Traded Concepts investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Exchange Traded Concepts consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Exchange Traded Concepts
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $902k | 19k | 46.98 |
| 2024-06-30 | $844k | 16k | 54.01 |
| 2024-03-31 | $817k | 12k | 68.16 |
| 2023-03-31 | $1.0M | 22k | 45.23 |
| 2021-03-31 | $42k | 342 | 122.81 |
| 2020-12-31 | $46k | 303 | 151.82 |
| 2020-09-30 | $467k | 5.6k | 83.57 |
| 2020-06-30 | $302k | 4.1k | 73.46 |
| 2020-03-31 | $91k | 2.1k | 42.37 |
| 2019-12-31 | $54k | 894 | 60.40 |